SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported):
July 29, 2004

 

HARVARD BIOSCIENCE, INC.

(Exact Name of Registrant as specified in its charter)

 

Delaware

 

0-31923

 

04-3306140

(State or other jurisdiction
of incorporation)

 

(Commission File
Number)

 

(I.R.S. Employer
Identification No.)

 

84 October Hill Road, Holliston, MA 01746-1371

(Address of principal executive offices and zip code)

 

(508) 893-8999

(Registrant’s telephone number, including area code)

 

 



 

ITEM 7.                             EXHIBITS

 

(c)           Exhibits.  The following exhibits are being furnished herewith:

 

Exhibit
Number

 

Title

 

 

 

99.1

 

Press release of Harvard Bioscience, Inc. issued on July 29, 2004

 

ITEM 12.                       RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

On July 29, 2004, Harvard Bioscience, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2004.  Copies of Harvard Bioscience, Inc.’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

[Remainder of page intentionally left blank]

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated:  July 30, 2004

HARVARD BIOSCIENCE, INC.

 

 

 

 

 

 

 

By:

 /s/ Susan M. Luscinski

 

 

 

Susan M. Luscinski

 

 

Chief Financial Officer

 

3



 

EXHIBIT INDEX

 

Exhibit
Number

 

Title

 

 

 

99.1

 

Press release of Harvard Bioscience, Inc. issued on July 29, 2004

 

4